rs1555445685
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001271.4(CHD2):c.4771_4772delCT(p.Leu1591fs) variant causes a frameshift change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Consequence
CHD2
NM_001271.4 frameshift
NM_001271.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 4.43
Genes affected
CHD2 (HGNC:1917): (chromodomain helicase DNA binding protein 2) The CHD family of proteins is characterized by the presence of chromo (chromatin organization modifier) domains and SNF2-related helicase/ATPase domains. CHD genes alter gene expression possibly by modification of chromatin structure thus altering access of the transcriptional apparatus to its chromosomal DNA template. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 15-93014769-ACT-A is Pathogenic according to our data. Variant chr15-93014769-ACT-A is described in ClinVar as [Pathogenic]. Clinvar id is 521424.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHD2 | NM_001271.4 | c.4771_4772delCT | p.Leu1591fs | frameshift_variant | 37/39 | ENST00000394196.9 | NP_001262.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHD2 | ENST00000394196.9 | c.4771_4772delCT | p.Leu1591fs | frameshift_variant | 37/39 | 5 | NM_001271.4 | ENSP00000377747.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 29, 2016 | - - |
CHD2-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 19, 2022 | The CHD2 c.4771_4772delCT variant is predicted to result in a frameshift and premature protein termination (p.Leu1591Aspfs*32). This variant was reported to have occurred de novo in two individuals with developmental and epileptic encephalopathy (described as c.4767_4768delCT p.(Leu1591Aspfs), Strauss et al. 2018. PubMed ID: 28726809; De Maria et al. 2021. PubMed ID: 34713950). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Frameshift variants in CHD2 are expected to be pathogenic. This variant is interpreted as pathogenic. - |
Developmental and epileptic encephalopathy 94 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 30, 2019 | This variant has been observed in individual(s) with epileptic encephalopathy (PMID: 28726809). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 521424). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Leu1591Aspfs*32) in the CHD2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CHD2 are known to be pathogenic (PMID: 23708187, 24207121). For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at